Etudes Non Stop Study Non Stop
Related Articles
The Therapeutic Innovation Center (THINC) at Baylor College of Medicine (BCM) invites applications for a tenure-track Assistant Professor, Associate Professor, or Professor position for colleagues that leverage chemical biology to study all facets of gene control, especially RNA regulation. Applicants’ research programs should focus on developing or utilizing chemical tool compounds to interrogate RNA biology, or a related field of biology, and create or repurpose current therapeutics as an intervention in diseases of aberrant gene control. Diverse research programs studying any level of gene control, particularly RNA regulation, are welcome.
THINC (thincbcm.org) is a center of excellence at BCM that seeks to discover fundamental mechanisms of gene control, especially RNA and chromatin regulation, and to translate these discoveries into early therapeutic campaigns. THINC brings together colleagues across BCM and the Texas Medical Center who study gene regulation from multiple disciplines and are leveraging these discoveries in diseases of aberrant gene control including cancer, neurodegeneration, and infectious disease. In addition to THINC member faculty labs, THINC also includes a dedicated team of scientists with expertise in therapeutic development including molecular, chemical, and computational biologists. This team drives the development of technology platforms and therapeutic campaigns aligned with the strategic goals of THINC member labs.
BCM is the premier medical school of Texas and has the top-ranked Genetics and Cell Biology Departments in the U.S. based on NIH funding. BCM has internationally recognized strengths in structural biology and biochemistry, a long-standing NIH human genome sequencing center, cutting edge Advanced Technology Cores, exceptional Ph.D. graduate programs, a commitment to technology transfer for faculty discoveries, and a rich history of translating basic science into clinical implementation. BCM is also home to the NCI-designated Dan L. Duncan Comprehensive Cancer Center (bcm.edu/centers/cancer-center) and centered in Texas Medical Center, the world’s largest biomedical research complex.
THINC and BCM offer premier recruitment packages and resources to enhance the candidate’s research program. Applicants should email a PDF of their curriculum vitae, a 4-page research statement, and a cover letter stating the position to which they are applying to THINC-communications@bcm.edu. Applicants should also request 3 letters of reference to be emailed directly from recommenders to THINC-communications@bcm.edu. All materials should be received by October 3, 2021.
Review of qualified applicants will begin October 11, 2021.
Baylor College of Medicine is an Equal Opportunity, Affirmative Action, and Equal Access Employer.
